ESR1 and triple-negative breast carcinoma: Usually, tamoxifen is used for ER-positive (ER+ve) breast cancer, Herceptin is used for HER2-overexpressed (HER2+ve) breast cancer, and chemotherapy is used for triple-negative breast cancer (TNBC).